Company Filing History:
Years Active: 2016
Title: Sanjit Kumar Mahato: Innovator in Medical Treatments
Introduction
Sanjit Kumar Mahato is a prominent inventor based in Kolkata, India. He has made significant contributions to the field of medical treatments, particularly in the development of compounds aimed at addressing serious health conditions. With a total of 2 patents to his name, Mahato's work is recognized for its potential impact on patient care.
Latest Patents
Mahato's latest patents include innovative compounds designed for the treatment of bronchial asthma and malignancies. The first patent focuses on "Substituted catechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma." This invention relates to compounds that inhibit the IL-4 or IL-5 pathways, providing a method for treating asthma through various administration routes. The second patent addresses "Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)." This invention aims to treat malignancies by inhibiting the PI3-Akt pathway and inducing nitric oxide, offering a promising approach to cancer treatment.
Career Highlights
Sanjit Kumar Mahato is affiliated with the Council of Scientific & Industrial Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving health outcomes through scientific discovery.
Collaborations
Mahato collaborates with esteemed colleagues, including Santu Bandyopadhyay and Bikas Chandra Pal. These partnerships enhance the research environment and foster the development of groundbreaking medical solutions.
Conclusion
Sanjit Kumar Mahato's contributions to medical science through his patents reflect his dedication to improving health care. His innovative approaches to treating bronchial asthma and malignancies highlight the importance of research in developing effective therapies.